<SEC-DOCUMENT>0001104659-25-013980-index.html : 20250327 <SEC-HEADER>0001104659-25-013980.hdr.sgml : 20250327 <ACCEPTANCE-DATETIME>20250214152432 <PRIVATE-TO-PUBLIC> ACCESSION NUMBER: 0001104659-25-013980 CONFORMED SUBMISSION TYPE: DRS PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20250214 <PUBLIC-REL-DATE>20250327 DATE AS OF CHANGE: 20250214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALUMIS INC. CENTRAL INDEX KEY: 0001847367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DRS SEC ACT: 1933 Act SEC FILE NUMBER: 377-07730 FILM NUMBER: 25627477 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-231-6625 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ESKER THERAPEUTICS, INC. DATE OF NAME CHANGE: 20230427 FORMER COMPANY: FORMER CONFORMED NAME: FL2021-001, Inc. DATE OF NAME CHANGE: 20210222 </SEC-HEADER> <DOCUMENT> <TYPE>DRS <SEQUENCE>1 <FILENAME>filename1.htm <TEXT> Document 1 - file: filename1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>ht_morganstanley-bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: ht_morganstanley-bw.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>lg_acelyrin-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: lg_acelyrin-4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>lg_alumis-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: lg_alumis-4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>lg_guggenheim-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: lg_guggenheim-4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tb_pipeline-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tb_pipeline-4c.jpg
</DOCUMENT> </SEC-DOCUMENT>